Aquestive Therapeutics, Inc. (AQST)

$4.78 0.22 (4.82%)

in Medical - Devices & Equipment

Aquestive Therapeutics, Inc. (AQST)

$4.78 USD

0.22 (4.82%)

Updated Jun 18 6:55pm

Add AQST to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

Trade Grade Buy & Hold Grade Peer Grade Industry Rank

Industry Rank:

Ranked of 131 in Medical - Devices & Equipment

See all “A” rated Strong Buy stocks

AQST Daily Price Range

AQST 52-Week Price Range

Learn More About POWR Ratings

AQST News Stream

Event/Time	News Detail	Start	End	Change
Loading, please wait...

View All AQST News

Aquestive Therapeutics, Inc. (AQST) Company Bio

Aquestive Therapeutics, Inc. operates as a specialty pharmaceutical company that specializes in the drug delivery technology. The company offers PharmFilm, a drug delivery platform/pharmaceutical dosage form that delivers existing prescription products directly to the bloodstream. It develops, manufactures, and commercializes pharmaceutical films, individual film doses, and finished products for patients, physicians, and caregivers. Aquestive Therapeutics, Inc. was formerly known as MonoSol Rx Inc. and changed its name to Aquestive Therapeutics, Inc. in November 2017. The company was founded in 2000 and is based in Warren, New Jersey.

AQST Stock Chart More Charts

AQST Price/Volume Stats

Current price	$4.78
Prev. close	$4.56
Day low	$4.56
Day high	$4.82
50-day MA	$5.10
200-day MA	$9.39
52-week high	$20.70
52-week low	$3.65
Volume	130,000
Avg. volume	114,045
Dividend yield	N/A
Market Cap	119.38M

AQST Social Stream

View Full AQST Social Stream

AQST Returns

1-mo	-11.15%
3-mo	-31.22%
6-mo	-26.57%
1-year	N/A
3-year	N/A
5-year	N/A

YTD	-24.13%
2018	N/A
2017	N/A
2016	N/A
2015	N/A
2014	N/A

Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics, Inc. (AQST)

Overall POWR Rating

POWR Components:

Industry Rank:

See all “A” rated Strong Buy stocks

AQST News Stream

Aquestive Therapeutics, Inc. (AQST) Company Bio

AQST Stock Chart More Charts

AQST Price/Volume Stats

AQST Social Stream

AQST Returns

Top Stories View All

J.B. Hunt (JBHT) receives a downgrade from UBS

Morgan Stanley upgrades US Cellular Corp. (USM)

Are shares of Aurora Cannabis (ACB) a good investment?

Google (GOOGL) announces it will invest $1 billion in affordable housing efforts in the San Francisco Bay Area

Adobe Inc. (ADBE) reports earnings, beats earnings estimates